Health Insurance Stocks Surge as SCHD ETF Undergoes Major Reconstitution

Health insurance stocks rallied significantly following a larger-than-expected boost to Medicare Advantage payment rates by federal regulators. The favorable regulatory update has bolstered profit outlooks for major insurers, driving positive momentum across the healthcare sector. Meanwhile, the Schwab U.S. Dividend Equity ETF (SCHD) completed its most substantial portfolio rebalancing in years, with turnover reaching 31%. This major reconstitution reflects a strategic shift in the fund's holdings to align with current dividend yields and market conditions. Additionally, retail investor interest has peaked for large-cap names such as Amgen, Eli Lilly, Alibaba, and Dell, according to search data from Zacks.com. The convergence of regulatory tailwinds and high retail engagement suggests a dynamic period for both dividend-focused and growth-oriented investors.